Diabetes drug trial offers new hope for stubborn asthma
NCT ID NCT06273072
Summary
This study is testing whether metformin, a common diabetes medication, can help control asthma in overweight or obese adults whose asthma isn't well-managed with standard inhalers. 100 participants will take either metformin or a placebo pill daily for six months while researchers monitor their asthma symptoms and lung function. The main goal is to see if this approach is practical and safe enough to justify a larger future trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21224, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.